KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Intangibles (2021 - 2025)

Fulgent Genetics' Intangibles history spans 5 years, with the latest figure at $64.8 million for Q4 2025.

  • For Q4 2025, Intangibles fell 7.95% year-over-year to $64.8 million; the TTM value through Dec 2025 reached $64.8 million, down 7.95%, while the annual FY2025 figure was $64.8 million, 7.95% down from the prior year.
  • Intangibles for Q4 2025 was $64.8 million at Fulgent Genetics, down from $135.3 million in the prior quarter.
  • Across five years, Intangibles topped out at $150.6 million in Q4 2022 and bottomed at $6.8 million in Q2 2021.
  • The 5-year median for Intangibles is $112.5 million (2022), against an average of $99.1 million.
  • The largest annual shift saw Intangibles soared 1213.44% in 2022 before it plummeted 50.8% in 2024.
  • A 5-year view of Intangibles shows it stood at $35.9 million in 2021, then surged by 319.45% to $150.6 million in 2022, then dropped by 5.04% to $143.1 million in 2023, then tumbled by 50.8% to $70.4 million in 2024, then decreased by 7.95% to $64.8 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Intangibles are $64.8 million (Q4 2025), $135.3 million (Q3 2025), and $135.3 million (Q2 2025).